Cargando…
Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
Lung cancer is the most frequent cancer with an aggressive clinical course and high mortality rates. Most cases are diagnosed at advanced stages when treatment options are limited and the efficacy of chemotherapy is poor. The disease has a complex and heterogeneous background with non-small-cell lun...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352653/ https://www.ncbi.nlm.nih.gov/pubmed/32560574 http://dx.doi.org/10.3390/ijms21124325 |